Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Endoplasmic reticulum stress is a target for therapy in Waldenstrom macroglobulinemia

Blood (2009) 113 (3): 626–634.

https://doi.org/10.1182/blood-2007-10-116848

Published: 2009

Journal Articles

CD27-CD70 interactions in the pathogenesis of Waldenström macroglobulinemia

Allen W. Ho, Evdoxia Hatjiharissi, Bryan T. Ciccarelli, Andrew R. Branagan, Zachary R. Hunter, Xavier Leleu, Olivier Tournilhac, Lian Xu, Kelly O'Connor, Robert J. Manning, Daniel Ditzel Santos, Mariana Chemaly, Christopher J. Patterson, Jacob D. Soumerai, Nikhil C. Munshi, Julie A. McEarchern, Che-Leung Law, Iqbal S. Grewal, Steven P. Treon

Blood (2008) 112 (12): 4683–4689.

https://doi.org/10.1182/blood-2007-04-084525

Published: 2008

Journal Articles

Phase I Trial of CCI-779 (Temsirolimus) and Weekly Bortezomib in Relapsed and/or Refractory Multiple Myeloma

Irene M. Ghobrial, M.D., Nikhil Munshi, MD, Robert Schlossman, MD, Stacey Chuma, RN, Renee Leduc, Marybeth Nelson, PA, Amy Sam, Kelly O’Connor, Brianna Harris, Diane Warren, Akari M. Dollard, Jacob Laubach, MD, Ravi Vij, MD, Erica Campagnaro, MD, Ann Birner, Virginia Dixon-Lipscomb, Kenneth C. Anderson, Paul G. Richardson

Blood (2008) 112 (11): 3696.

https://doi.org/10.1182/blood.V112.11.3696.3696

Published: 2008

Journal Articles

Final Results of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed and/or Refractory Waldenstrom Macroglobulinemia (WM).

Irene M. Ghobrial, M.D., Xavier Leleu, MD, PhD, Nancy Rubin, MD, Wanling Xie, Fangxin Hong, Stacey Chuma, RN, Renee Leduc, Marybeth Nelson, PA, Kelly O’Connor, Amy Sam, Brianna Harris, Diane Warren, Peter Sportelli, Steven P. Treon, MD, PhD, Edie Weller, PhD, Kenneth C. Anderson, MD, Paul G. Richardson, MD

Blood (2008) 112 (11): 1010.

https://doi.org/10.1182/blood.V112.11.1010.1010

Published: 2008

Journal Articles

Phase II Trial of the mTOR Inhibitor RAD001 in Relapsed and/or Refractory Waldenstrom Macroglobulinemia: The Dana Farber Cancer Institute Experience.

Irene M. Ghobrial, M.D., Stacey Chuma, RN, Amy Sam, Renee Leduc, Marybeth Nelson, PA, Kelly O’Connor, Brianna Harris, Jacob Soumerai, Diane Warren, Eric Jacobsen, MD, Daniel DeAngelo, MD, PhD, Kenneth C. Anderson, MD, Paul G. Richardson, MD, Thomas E. Witzig, MD, Steven P. Treon, MD, PhD

Blood (2008) 112 (11): 1011.

https://doi.org/10.1182/blood.V112.11.1011.1011

Published: 2008

Journal Articles

Phase II Trial of Combination of Bortezomib and Rituximab in Relapsed and/or Refractory Waldenstrom Macroglobulinemia

Irene M. Ghobrial, M.D., Jeffrey Matous, MD, Swaminathan Padmanabhan, MD, Ashraf Badros, MD, Robert Schlossman, MD, Stacey Chuma, RN, Renee Leduc1, Marybeth Nelson, PA, Kelly O’Connor, Amy Sam, Brianna Harris, Jacob Soumerai, Diane Warren, Ann Birner, Nikhil Munshi, MD, Steven P. Treon, MD, PhD, Kenneth C. Anderson, MD, Paul Richardson, MD

Blood (2008) 112 (11): 832.

https://doi.org/10.1182/blood.V112.11.832.832

Published: 2008

Journal Articles

Phase II Trial of the Oral mTOR Inhibitor RAD001 (Everolimus) in Relapsed and/or Refractory Waldenstrom Macroglobulinemia: Preliminary Results.

Irene M. Ghobrial, Renee Leduc, Marybeth Nelson, Xavier Leleu, Eric Jacobsen, Ann LaCasce, Daniel DeAngelo, David Fisher, Jennifer R. Brown, Robert Schlossman, Diane Warren, Jacob Soumerai, Kelly O’Connor, Nikhil Munshi, Paul Richardson, Kenneth C. Anderson, Thomas E. Witzig, Steven P. Treon

Blood (2007) 110 (11): 4496.

https://doi.org/10.1182/blood.V110.11.4496.4496

Published: 2007

Journal Articles

IgA and IgG Hypogammaglobulinemia Are Associated with Mutations in the APRIL/BLYS Receptor TACI in Waldenstrom’s Macroglobulinemia (WM).

Zachary Hunter, Xavier Leleu, Evdoxia Hatjiharissi, Daniel Santos, Lian Xu, Alan Ho, Vinod Bakthavachalam, Anne-Sophie Moreau, Kelly O’Connor, Jacob Soumerai, Christopher Patterson, Irene Ghobrial, Susanna Hamilton, Sigitas Verselis, Edward Fox, Steven Treon

Blood (2006) 108 (11): 228.

https://doi.org/10.1182/blood.V108.11.228.228

Published: 2006

Journal Articles

Abnormal Expression of TRAF Adapter Proteins in Waldenstrom’s Macroglobulinemia.

Xavier Leleu, MD, Lian Xu, Zachary R. Hunter, Anne-Sophie Moreau, MD, Xiaoying Jia, Garrett O’Sullivan, Vinod Bakthavachalam, Allen W. Ho, Evdoxia Hatjiharissi, MD, Hai T. N’Go, Daniel D. Santos, MD, Kelly O’Connor, Robert Manning, Jacob Soumerai, Christopher Patterson, Irene M. Ghobrial, MD, Steven P. Treon, MD

Blood (2006) 108 (11): 4640.

https://doi.org/10.1182/blood.V108.11.4640.4640

Published: 2006

Journal Articles

Endoplasmic Reticulum Stress Is a Target for Therapy in Waldenstrom’s Macroglobulinemia (WM).

Xavier Leleu, MD, Lian Xu, Zachary R. Hunter, Xiaoying Jia, Anne-Sophie Moreau, MD, Allen W. Ho, Evdoxia Hatjiharissi, MD, Hai N’Go, Daniel D. Santos, MD, Kelly O’Connor, Robert Manning, Jacob Soumerai, Christopher Patterson, Irene M. Ghobrial, MD, Steven P. Treon, MD

Blood (2006) 108 (11): 4641.

https://doi.org/10.1182/blood.V108.11.4641.4641

Published: 2006

Journal Articles

The Unfolded Protein Response Is a Determinant of Disease Actvity in Waldenstrom’s Macroglobulinemia (WM).

Xavier Leleu, MD, Lian Xu, Daniel D. Santos, MD, Allen W. Ho, Zachary R. Hunter, Kelly O’Connor, Robert J. Manning, Olivier Tournilhac, MD, Mariana Chemaly, Andrew R. Branagan, Christopher J. Patterson, Kenneth C. Anderson, MD, Steven Treon, MD

Blood (2005) 106 (11): 996.

https://doi.org/10.1182/blood.V106.11.996.996

Published: 2005

Journal Articles

Abnormal Expression of the Plasma Cell Differentiation Factor X-Box Protein 1 (Xbp-1) in Waldenstrom’s Macroglobulinemia.

Lian Xu, Xavier Leleu, MD, Zachary R. Hunter, Daniel D. Santos, MD, Allen W. Ho, Evdoxia Hatjiharissi, MD, Kelly O’Connor, Robert J. Manning, Mariana Chemaly, Andrew R. Branagan, Christopher J. Patterson, Sigitas Verselis, Edward Fox, Kenneth C. Anderson, MD, Steven Treon, MD

Blood (2005) 106 (11): 1003.

https://doi.org/10.1182/blood.V106.11.1003.1003

Published: 2005

Journal Articles

Hepatitis C Viral Infection Is Not Associated with Waldenstrom’s Macroglobulinemia.

Xavier Leleu, MD, Kelly O’Connor, Allen Ho, Daniel D. Santos, MD, Robert Manning, Lian Xu, Evdoxia Hatjiharissi, MD, Olivier Tournilhac, MD, Mariana Chemaly, Andrew R. Branagan, Zachary R. Hunter, Christopher J. Patterson, Kenneth C. Anderson, MD, Steven Treon, MD, PhD

Blood (2005) 106 (11): 4693.

https://doi.org/10.1182/blood.V106.11.4693.4693

Published: 2005

Journal Articles

A Novel Functional Role for Soluble CD27 in the Pathogenesis of Waldenstrom’s Macroglobulinemia.

Allen W. Ho, Xavier Leleu, MD, Evdoxia Hatjiharissi, MD, Olivier Tournilhac, MD, Lian Xu, Kelly O’Connor, Robert Manning, Daniel Santos, MD, Mariana Chemaly, MD, Andrew Branagan, Zachary Hunter, Christopher Patterson, Kenneth C. Anderson, MD, Steven P. Treon, MD, PhD

Blood (2005) 106 (11): 4701.

https://doi.org/10.1182/blood.V106.11.4701.4701

Published: 2005

NARROW

Endoplasmic reticulum stress is a target for therapy in Waldenstrom macroglobulinemia

CD27-CD70 interactions in the pathogenesis of Waldenström macroglobulinemia

Phase I Trial of CCI-779 (Temsirolimus) and Weekly Bortezomib in Relapsed and/or Refractory Multiple Myeloma

Final Results of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed and/or Refractory Waldenstrom Macroglobulinemia (WM).

Phase II Trial of the mTOR Inhibitor RAD001 in Relapsed and/or Refractory Waldenstrom Macroglobulinemia: The Dana Farber Cancer Institute Experience.

Phase II Trial of Combination of Bortezomib and Rituximab in Relapsed and/or Refractory Waldenstrom Macroglobulinemia

Phase II Trial of the Oral mTOR Inhibitor RAD001 (Everolimus) in Relapsed and/or Refractory Waldenstrom Macroglobulinemia: Preliminary Results.

IgA and IgG Hypogammaglobulinemia Are Associated with Mutations in the APRIL/BLYS Receptor TACI in Waldenstrom’s Macroglobulinemia (WM).

Abnormal Expression of TRAF Adapter Proteins in Waldenstrom’s Macroglobulinemia.

Endoplasmic Reticulum Stress Is a Target for Therapy in Waldenstrom’s Macroglobulinemia (WM).

The Unfolded Protein Response Is a Determinant of Disease Actvity in Waldenstrom’s Macroglobulinemia (WM).

Abnormal Expression of the Plasma Cell Differentiation Factor X-Box Protein 1 (Xbp-1) in Waldenstrom’s Macroglobulinemia.

Hepatitis C Viral Infection Is Not Associated with Waldenstrom’s Macroglobulinemia.

A Novel Functional Role for Soluble CD27 in the Pathogenesis of Waldenstrom’s Macroglobulinemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only